Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Abstract
The purpose of this study was to assess the reliability of treatment decisions based on MDCT angiographic findings of stage IIb peripheral arterial occlusive disease (PAOD).Fifty-eight patients with stage IIb PAOD underwent CT angiography of the abdominal aorta and runoff vessels for further treatment planning. Treatment reports, discharge summaries, and follow-up examinations were reviewed to determine the number of treatments correctly planned on the basis of CT angiographic findings.On the basis of CT angiographic findings, endovascular treatment was indicated for 18 patients, surgical revascularization for nine patients, and a combined endovascular and surgical approach for two patients. Conservative treatment was indicated for 29 patients. On the basis of successful revascularization, the correctness of the treatment decision was confirmed in all but one patient (n = 28). The treatment plan was modified for one patient referred for surgical revascularization. In that patient, stenosis of the common femoral artery had been overlooked on CT angiography. Patients for whom conservative management was indicated on the basis of CT angiographic findings (n = 29) had a mean follow-up period of 501 days without needing revascularization treatment. This result was defined as indirect confirmation of the accuracy of the decision made with CT angiography.The findings on MDCT angiography led to correct treatment recommendations for patients with claudication. Thus, CT angiography should be used in the management of PAOD.
View details for DOI 10.2214/AJR.07.2054
View details for Web of Science ID 000250518500033
View details for PubMedID 17954664